-
Protocol for the development of a core outcome set for clinical trials in primary sclerosing cholangitis June 26, 2024 11:00 AMHussain N, Ma C, Hirschfield G, Walmsley M, Hanford P, Vesterhus M, Kowdley K, Bergquist A, Ponsioen C, Levy C, Assis D, Schramm C, Bowlus C, Trauner M, Aiyegbusi OL, Jairath V, Trivedi PJ (2024) Protocol for the development of a core outcome set for clinical trials in primary sclerosing cholangitis BMJ Open, 14 (6), e080143 PubMed 38926149 DOI 10.1136/bmjopen-2023-080143
-
Comparing Survival of Perihilar Cholangiocarcinoma After R1 Resection Versus Palliative Chemotherapy for Unresected Localized Disease June 19, 2024 11:00 AMvan Keulen AM, Buettner S, Olthof PB, Klümpen HJ, Erdmann JI, Izquierdo-Sanchez L, Banales JM, Goeppert B, Roessler S, Zieniewicz K, Lamarca A, Valle JW, La Casta A, Hoogwater FJH, Donadon M, Scheiter A, Marzioni M, Adeva J, Kiudeliene E, Fernández JMU, Vidili G, Mocan T, Fabris L, Krawczyk M, Folseraas T, Dopazo C, Detry O, Voiosu T, Scripcariu V, Biancaniello F, Braconi C, Macias RIR, Groot Koerkamp B (2024) Comparing Survival of Perihilar Cholangiocarcinoma After R1 Resection Versus Palliative Chemotherapy for Unresected Localized Disease Ann Surg Oncol PubMed 38896226 DOI 10.1245/s10434-024-15582-5
-
Intergenic risk variant rs56258221 skews the fate of naive CD4<sup>+</sup> T cells via miR4464-BACH2 interplay in primary sclerosing cholangitis June 20, 2024 11:00 AMPoch T, Bahn J, Casar C, Krause J, Evangelakos I, Gilladi H, Kunzmann LK, Laschtowitz A, Iuso N, Schäfer AM, Liebig LA, Steinmann S, Sebode M, Folseraas T, Engesæter LK, Karlsen TH, Franke A, Hubner N, Schlein C, Galun E, Huber S, Lohse AW, Gagliani N, Schwinge D, Schramm C (2024) Intergenic risk variant rs56258221 skews the fate of naive CD4+ T cells via miR4464-BACH2 interplay in primary sclerosing cholangitis Cell Rep Med, 101620 PubMed 38901430 DOI 10.1016/j.xcrm.2024.101620
-
Altered Genome-Wide DNA Methylation in the Duodenum of Common Variable Immunodeficiency Patients May 23, 2024 11:00 AMYang M, Kaarbø M, Myhre V, Reims HM, Karlsen TH, Wang J, Rognes T, Halvorsen B, Fevang B, Lundin KEA, Aukrust P, Bjørås M, Jørgensen SF (2024) Altered Genome-Wide DNA Methylation in the Duodenum of Common Variable Immunodeficiency Patients J Clin Immunol, 44 (6), 133 PubMed 38780872 DOI 10.1007/s10875-024-01726-5
-
Gut Microbiota Alterations and Circulating Imidazole Propionate Levels Are Associated With Obstructive Coronary Artery Disease in People With HIV Jan. 9, 2024 10:00 AMTrøseid M, Molinaro A, Gelpi M, Vestad B, Kofoed KF, Fuchs A, Køber L, Holm K, Benfield T, Ueland PM, Hov JR, Nielsen SD, Knudsen AD (2024) Gut Microbiota Alterations and Circulating Imidazole Propionate Levels Are Associated With Obstructive Coronary Artery Disease in People With HIV J Infect Dis, 229 (3), 898-907 PubMed 38195204 DOI 10.1093/infdis/jiad604
-
T cells with increased responsiveness cause obesity in mice without diet intervention Mar. 29, 2024 10:00 AMGregersen I, Kong XY, Kooijman S, Foyn H, Grannes H, Olsen MB, Lone AM, Yang K, Quiles-Jiménez A, Tran M, Øgaard J, Segers FM, Rashidi A, Sagen EL, Lauritzen KH, Pronk ACM, de Boer JF, Holven KB, Melum E, Aukrust P, Taskén K, Holm S, Rensen PCN, Dahl TB, Halvorsen B (2024) T cells with increased responsiveness cause obesity in mice without diet intervention iScience, 27 (4), 109471 PubMed 38551005 DOI 10.1016/j.isci.2024.109471
-
Cell-Free Microbial DNA Analysis: Effects of Blood Plasma and Serum Quantity, Biobanking Protocols, and Isolation Kits Feb. 28, 2024 10:00 AMNikitina D, Lukosevicius R, Tilinde D, Muskieta T, Hov JR, Melum E, Klovins J, Org E, Kiudelis G, Kupcinskas J, Skieceviciene J (2024) Cell-Free Microbial DNA Analysis: Effects of Blood Plasma and Serum Quantity, Biobanking Protocols, and Isolation Kits Biopreserv Biobank PubMed 38416864 DOI 10.1089/bio.2023.0048
-
Retraction Note: Rifaximin alters gut microbiota profile, but does not affect systemic inflammation - a randomized controlled trial in common variable immunodeficiency Feb. 14, 2024 10:00 AMJørgensen SF, Macpherson ME, Bjørnetrø T, Holm K, Kummen M, Rashidi A, Michelsen AE, Lekva T, Halvorsen B, Trøseid M, Mollnes TE, Berge RK, Yndestad A, Ueland T, Karlsen TH, Aukrust P, Hov JR, Fevang B (2024) Retraction Note: Rifaximin alters gut microbiota profile, but does not affect systemic inflammation - a randomized controlled trial in common variable immunodeficiency Sci Rep, 14 (1), 3704 PubMed 38355714 DOI 10.1038/s41598-024-54117-6
-
The EASL-Lancet Commission on liver health in Europe: prevention, case-finding, and early diagnosis to reduce liver-related mortality Feb. 15, 2024 10:00 AMKarlsen TH, Rutter H, Carrieri P, Zelber-Sagi S, Engebretsen E, Hutchinson S, Voigt K, Guha N, Berzigotti A, Schomerus G, Gines P, Buti M, Burra P, Manns MP, Krag A, Kleinert S (2024) The EASL-Lancet Commission on liver health in Europe: prevention, case-finding, and early diagnosis to reduce liver-related mortality Lancet, 403 (10436), 1522-1524 PubMed 38359860 DOI 10.1016/S0140-6736(24)00204-6
-
Microbial-derived imidazole propionate links the heart failure-associated microbiome alterations to disease severity Feb. 8, 2024 10:00 AMRaju SC, Molinaro A, Awoyemi A, Jørgensen SF, Braadland PR, Nendl A, Seljeflot I, Ueland PM, McCann A, Aukrust P, Vestad B, Mayerhofer C, Broch K, Gullestad L, Lappegård KT, Halvorsen B, Kristiansen K, Hov JR, Trøseid M (2024) Microbial-derived imidazole propionate links the heart failure-associated microbiome alterations to disease severity Genome Med, 16 (1), 27 PubMed 38331891 DOI 10.1186/s13073-024-01296-6
Publication lists of articles generated by Publika.